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IDENTIFICATION OF DISEASES FOR EQ-5D BOLT-ON ITEM DEVELOPMENT: AN
EMPIRICAL APPROACH
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OBJECTIVES: A perceived limitation of generic utility measures is lack of ability to
capture change relevant to disease-specific areas or interventions. To test whether
core EQ-5D items sufficiently measure variability in patients’ self-reported quality
of life scores, we aimed to identify whether the presence of a series of conditions
explained residual variability in EQ-5D visual analog scale (VAS) scores, beyond
EQ-5D items. METHODS: We utilized generalized linear models (GLM) with a
gamma distribution and log link to predict VAS by the 5 EQ-5D items and the
presence/absence of 10 conditions (cancer, diabetes, anxiety disorder, hyperten-
sion, coronary heart disease, stroke, asthma, COPD/other respiratory, depression,
glaucoma), controlling for age, gender, race/ethnicity and number of chronic con-
ditions (i.e., as a proxy for co-morbidities) using the 2000-2003 Medical Expenditure
Panel Survey (MEPS) data. Coefficients for disease that were statistically significant
(p-value0.01) and showed minimally important difference (MID: coefficient
0.03) served as criteria to support further investigation of condition-specific “bolt-
on” items that extend the content of EQ-5D.RESULTS:Of 24,830 respondents, 45.7%
were male, 77.2% were white non-Hispanic and had a mean age of 45.9 years (SD
17.1). Overall mean EQ-VAS was 79.75 at first measurement. Diabetes, stroke and
depression significantly predicted VAS scores alongside the EQ-5D items and de-
mographic characteristics (p0.001) and met MID criteria. When concurrently con-
trolling for all other conditions, cancer, CHD and COPD also met criteria.
CONCLUSIONS: Findings suggest respondents with diabetes, stroke, and depres-
sion, potentially with cancer, CHD and COPD, had significant heterogeneity in their
VAS valuation of their own health that was not explained alone by EQ-5D items or
demographics. This study provides one approach to identifying potential chronic
conditions where disease-specific “bolt-on” items may be considered for EQ-5D.
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IMPROVING THE MEASUREMENT OF QUALITY OF LIFE BASED ON FUZZY SCALE
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OBJECTIVES: In past two decades, researchers have proposed to combine fuzzy
theory into measurement in various areas. According to their studies, combining
fuzzy theory could reduce the properties differences between measurement meth-
ods and human cognition, and the results collected by fuzzy scale(FS) were also
superior to those by traditional measurement in both validity and reliability.
Therefore, the purpose of this study tries to measure the quality of life(QOL) by FS,
and examine its own psychometrical properties and comparability with Likert
scale(LS). METHODS: WHOQOL-BREF Taiwan version was used to compare the
results collected by FS and LS, with a set of data from 404 subjects in repeated
experiment design. Cronbach’s alpha and hypothesis test of reliability coefficient
were utilized to compare the reliability of WHOQOL-BREF in both two measure-
ment. Confirmatory factor analysis(CFA) was used to examine the construct valid-
ity and measurement invariance (ME/I) between LS and FS at domain level.
RESULTS: The results indicated that Cronbach’s alpha coefficients of FS were sig-
nificant higher than that of LS in most domains. Moreover, CFA analysis showed
that the equal intercept invariance model between FS and LS measurement were
supported, all fit index performed well under the factor model at domain level, CFI,
RMSEA and SRMR increased very slightly after imposing the equal intercept con-
strain proposed by Meredith in 1993. CONCLUSIONS: According to the above re-
sults, FS did improve QOL measurement in reducing the measurement error, and
its construct validity was supported by CFA analysis. Besides, the ME/I analysis
indicated that FS was still comparable with traditional LS in the lower measure-
ment error of QOL. In future studies, researchers may use previous studies which
incorporating fuzzy scale in helping them diagnose and differentiate psychiatric
diseases as reference, and look into how the fuzzy scale QOL could be used in other
medical fields.
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ARE GENERAL POPULATION DATA SUITABLE FOR APPROXIMATING BASELINE
UTILITY VALUES IN ECONOMIC MODELS?
Ara R, Brazier J
University of Sheffield, Sheffield, UK
OBJECTIVES: Economic models require a baseline utility profile to assess the num-
ber of quality adjusted life years (QALY) gained from an intervention. The baseline
needed could be obtained from individuals without a specific health condition,
depending on the definition of the health condition in the model. We explored
whether utilities from the general population are suitable as proxy measures when
condition specific data are not available. METHODS: Pooling data from four con-
secutive rounds of the Health Survey for England (n41,000) and using sub-groups
stratified by self-reported health conditions, we compared mean utility scores (EQ-
5D) for groups without specific conditions (i.e. the preferred baseline profile) with
the mean scores from similar aged cohorts of the general population (i.e. the proxy
baseline profile). RESULTS: We found the average utility scores from the general
population were good approximations for some conditions (e.g. cancer) but not all
(e.g. complaints of teeth/mouth). For cohorts who have just one single condition,
data from the general population who report they do not have any of the prevalent
conditions could be used to approximate the baseline. CONCLUSIONS: We present
a number of health condition and age-stratified preference-based utility values
that could be used to assess the QALY gain compared to the average person who
does not have that condition. We also provide age stratified data from the general
population that could be used to approximate baseline preference-based utility
scores when condition specific data are not available.
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OBJECTIVES: In order to estimate the benefits of health interventions, health re-
lated quality of life (HR-QoL) measures are traditionally mapped into utilities based
on a valuation by a representative sample of the general population. However, in
order to apply such valuations in cost-effectiveness studies of programs addressed
to patients, it needs to be ascertained that the values of these patients are not
different than these of the population. Therefore we compared the valuation of
chronic patients with the already published valuation of the general population.
METHODS: Between December 2009 and March 2010 the EQ-5D questionnaire was
distributed in 15 outpatient services, treating adult (age  18 yrs) chronically ill
patients in the University Hospital Ghent, Belgium. In Belgium the EQ-5D was
mapped previously to the Visual Analogue Score (VAS), hence patients in our study
were also asked to indicate their actual perception of HR-QoL on a VAS scale. Only
EQ-5D profiles which were scored at least 10 times by different patients were con-
sidered for further evaluation. All profiles were mapped into VAS by multivariate
regression. RESULTS: A total of 1348 questionnaires were distributed, of which 768
(57%) were completed. Male/female ratio was 41%/59%, with a mean age of 53.6.
Eighteen EQ-5D profiles were scored at least 10 times, with a mean VAS of 0.64 (95%
C.I. 0.63-0.66). The complete set of utilities obtained by multivariate regression was
significantly different compared to the valuation by the Belgian population sample
(p0.0001). Especially in the profiles in which the patient indicates complete de-
pendency or major problems, the HR-QoL value was perceived much higher by
patients as compared to the general population. CONCLUSIONS: Chronically ill
patients perceive their HR-QoL higher than estimated by the population sample. In
order to evaluate health programs consequences of these findings should be con-
sidered.
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OBJECTIVES: To illustrate patient needs and preferences for patient diaries in sup-
port of clinical trials and to identify what can be done to improve the electronic
patient diary experience based on the patients’ recommendations. METHODS:
Three hundred seven participants (45% female and 55% male) completed a 10-
minute internet survey, fielded in December 2010. The age range of the patients
was 19-77 years. This internet survey focused on patients’ perceived benefits and
experience with current patient diaries and asked where improvements could be
made RESULTS: From the survey positive experiences reported by patients were
ease of use (66%) and simple questions (60%). 48% found no unfavorable aspects in
diary keeping but 38% said that diary entries were too frequent. Patients were
asked about the use of reminders and 80% stated that they would like to receive
reminders via email and 55% via SMS text. With regard to the patient suggested
improvements, 59% stated multiple options and more flexibility in keeping the
diary would improve their experience and 58% said to shorten the time needed to
make a diary entry. Further results will be presented. CONCLUSIONS: Simplicity
came out as a key factor in patients’ use of electronic diaries and should be first
priority when designing them. Patients would like to feel involved in the trial and
the use of reminders when they need to complete an action was a patient prefer-
ence. These factors should be considered when designing an ePRO system to be
used in a clinical trial.
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THE FIRST RESEARCH: ASSESSMENT OF THE WTP THRESHOLD FOR QALY BY
CONTINGENT VALUATION METHOD IN RUSSIA
Zelenova O
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and Social Development of Ru, Moscow, Russia
OBJECTIVES: To assess the WTP threshold for QALY in Russia.METHODS:We have
held the opinion poll to define WTP for QALY of the 980 respondents. Questionnaire
consists of demographic part: gender, age, education, hospitalization (within the
last 5 years), hospitalization of any member of household (within the last 5 years)
and occupation. The special part is a detailed 4categories of WTP: WTPsel for the
respondent’s additional QALY; WTP5sel for the respondent’s additional QALY 5
years later were used to establish decision making rules; WTPfam for an additional
QALY for a family member; WTPsoc: the cost that the respondent thought society
should pay for someone’s additional QALY were used to evaluate monetary value
of other people’s QALY for comparison with respondents’ own QALY. RESULTS:
Average WTPsel and WTP5sel are rather equal 69,000 and 72,000 rubles (the rub/$
rate in Russia is 30 rub for 1 $). The average WTPfam is 16% more than WTPsel.The
fact that WTPfam was higher than WTPsel. Average WTPsoc is 146 000 rubles,
which is more than twice as much as WTP5sel (72 000 rubles). WTP value is increas-
ing sequentially from WTPsel toWTPsoc in each category. The main factors which
influenced WTP the most are occupation, age and education. Whereas factors such
as gender, hospitalization (within the last 5 years) and hospitalization of any mem-
ber of household (within the last 5 years) didn’t play an important role. We have
compared our figures with International Survey (Takeru Shiroiwa, Japan) and have
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obtained the similar results. CONCLUSIONS: The WTP for QALY in Russia is 63,000
rubles or $2,300 that is much lower than in other countries but WTP/AAI ratio is
nearly the same as in the UK.There are WTP5selWTPselWTPfamWTPsocin
Russia just like in Australia, the UK and the US.
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IMPORTANCE OF COLLABORATION WITH DEVELOPERS IN THE CLARIFICATION
OF CONCEPTS: A CASE STUDY WITH THE UNIVERSITY OF CALIFORNIA, SAN
DIEGO (UCSD) SHORTNESS OF BREATH QUESTIONNAIRE (SOBQ)
Ries AL1, Kaschinski D2, Montigny C3
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OBJECTIVES: The UCSD SOBQ, a 24-item instrument developed in US English, as-
sesses self-reported shortness of breath while performing a variety of daily living
activities. The objective of this report is to underline the importance of collabora-
tion with the developers to clarify concepts and ensure their correct interpretation
while translating the original version into other languages. METHODS: Interactive
discussion with the developers of the SOBQ was undertaken to formalize a concept
list that would: 1) Explain and clarify the conceptual notions underlying each item
in simple language so they would be accurately reflected in each language version
produced, and 2) Provide acceptable approved translation alternatives. RESULTS:
The concept list was revised five times and widely expanded with definitions and
alternate translations validated by the developers. Through questions raised dur-
ing the linguistic validation process, collaboration with the developers highlighted
items initially considered as unambiguous but which required additional informa-
tion to be faithfully rendered in all languages. Among the 24 items of the SOBQ, four
items proved to be unclear (e.g., “dressing” was clarified as “putting on and taking
off clothes” and “picking up and straightening” as “picking things up and tidying
them up”). Three other items appeared as culturally inappropriate and, therefore,
needed to be adapted to be suitable to the countries for which these activities were
not relevant (e.g., “washing car or any other vehicle” was one of the accepted
alternatives for “washing car” and “watering flowers” for “watering the lawn”).
CONCLUSIONS: It is essential to involve the developers in the clarification of the
concepts underlying each item in a questionnaire to allow their correct interpre-
tation in other languages and cultures. This step is crucial to ensure comparable
content validity between different language versions. This example with the SOBQ
shows that the involvement of developers is a dynamic and necessary process.
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Zarzar KM1, Dawsey R2
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OBJECTIVES: As the use of clinical outcomes assessments in global studies contin-
ues to rise, and electronic modes of administration proliferate, collaboration be-
tween ePRO and linguistic validation providers becomes critical to the success of
global initiatives. This cooperation enables the incorporation of the electronic
mode of administration into the cognitive interviewing stage of linguistic valida-
tion, allowing respondents to view the content in context. Collaboration between
ePRO and linguistic validation providers also yields time and cost efficiencies to the
sponsor. METHODS: A review of prior collaboration with four ePRO providers was
conducted to provide insight into key areas for efficiency prior to initiation of a
large-scale linguistic validation project involving ePRO. Prior to project initiation, a
detailed workflow was outlined, a review of relevant ePRO file formats was con-
ducted, and processes and milestones were developed with input from the linguis-
tic validation provider, the ePRO provider, and the sponsor to ensure deadlines
were met. RESULTS: Reviews of prior projects revealed early collaboration was
commonly impeded as the development of the ePRO platform often initiates on
different timelines than linguistic validation process. Common reasons include
differing contracting timelines from the sponsor for each service, and addition of
countries or languages after ePRO contract execution. By building a collaborative
project workflow ahead of project initiation, the ePRO and linguistic validation
partners can identify cost and timeline efficiencies in 1) the source content, 2)
uploading the translated language directly into ePRO platforms, 3) use of ePRO
mode in cognitive interviews, 4) post-localization testing of fonts and characters,
and 5) proofreading of the final screenshots. CONCLUSIONS: Timeline restrictions
resulting from study deadlines and contracting processes can limit the benefit to be
achieved by collaboration between ePRO and linguistic validation partners. Early
planning, and contracting of each provider with the expectation of collaboration
will enable cost and timeline efficiencies, and process improvements.
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REVIEW OF CLINICIAN AND OBSERVER REPORTED OUTCOMES MEASURES
TRANSLATION METHODOLOGIES
Zarzar KM
TransPerfect, Durham, NC, USA
OBJECTIVES: Since the publication of the FDA PRO Guidance in 2009, focus has
largely been dedicated to patient-reported outcomes measures. Other commonly
used clinical outcomes assessments including clinician-reported outcomes (Clin-
RO) and observer-reported outcomes (Obs-RO) warrant attention, as the expecta-
tion is that all clinical outcomes assessments will be expected to follow the prop-
erties of the PRO guidelines. It can be inferred that the same expectations for
translation and cultural adaptation of these measures will also apply, and discus-
sion surrounding translation methodologies for these outcomes measures is
necessary. METHODS: A review of past Clin-RO and Obs-RO measure translation
methodologies was conducted. Linguistic feedback resulting from each stage was
reviewed for relevance and impact on language changes. RESULTS: Past transla-
tion methodologies involved concept definition, dual forward translation, recon-
ciliation of forward translations, back translation, resolution of back translation
and forward translation, and clinician or expert review for all clinical outcomes
assessments. An additional stage specific to observer-reported outcomes assess-
ments included cognitive interviewing with the relevant respondent population,
such as caregivers, parents, etc. Clin-RO measures involve review by native-speak-
ing clinicians in the relevant area of interest. Cognitive interviews with clinicians
were not found to be a common practice. CONCLUSIONS: The results of this review
and feedback analysis suggest observer-reported outcomes measures are best
suited to follow the same methodology as PRO measures, with the cognitive inter-
views conducted with the relevant observer population. Clinician-reported out-
comes measures should also follow the same guidelines as PRO measures for trans-
lation, however further research into the methodology for execution of the review
stage is required to assess if clinician reviews, focus groups with clinicians, cogni-
tive interviews with clinicians, or an alternative will yield the best results for this
particular clinical outcomes assessment.
Research On Methods – Statistical Methods
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A MODEL FOR PATIENTS ACCRUAL IN MULTI-SITE OBSERVATIONAL STUDIES:
A SURVIVAL ANALYSIS APPROACH
Longagnani C1, Bagnardi V2, Zanoli L1, Simoni L1
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OBJECTIVES: The allocation of sufficient time for participant recruitment is one of
the fundamental aspects in planning a clinical trial (Carter, 2004): the study of
patient accrual is of great interest not only in clinical trials but also in observational
studies. In this work we developed a time-to-event (i.e. survival) model aimed to
explain the course of patients, according to site and study characteristics.
METHODS: Nineteen observational non-retrospective studies (663 sites and 22,123
patients) managed by Medidata from 2002 to 2009 were included in the analysis.
Time to patient enrolment was calculated as the percentage of time elapsed from
the first-patient-in to the enrolment of the patient out of the study planned dura-
tion. Individuals enrolled after this period were considered as censored. Site and
study characteristics were included in a Cox Proportional Hazard regression model;
Hazard Ratios were estimated. RESULTS: The course of patients was significantly
associated with year of the study (2008 vs. 2008: Hazard Ratio 2.37), number of
planned sites (25 vs. 25: 0.63), study design (cross- sectional vs. longitudinal:
0.33), electronic vs. paper data capture (2.87), start-up and investigator meeting
execution (yes vs. no: 2.27 and 0.45 respectively), single patient fee vs. other (1.78),
top-enroller list communication (yes vs no: 0.71), competitive enrolment (yes vs.
no: 0.47), site initiation visit (yes vs. no: 0.38), protocol amendment with possible
effects on enrolment (yes vs. no: 4.21), type of site (academic private hospital/
university/private out-patient clinic vs community hospital: 0.86) and median
monthly number of phone calls/site (1.15). CONCLUSIONS: In our analysis, the
most interesting factors influencing patient accrual in the setting of observational
studies managed by an Italian CRO appeared to be the number of planned sites,
cross- sectional study design, electronic data capture, start-up and investigator
meeting execution, top-enroller list communication and competitive enrolment.
Further analyses are ongoing as regards a predictive model.
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EVALUATION OF BIVARIATE META-ANALYSIS METHODS TO SYNTHESISE
RESULTS OF SEVERAL STUDIES WITH TWO CORRELATED ENDPOINTS
Aballea S1, Vataire AL2, Neine ME3, Le coroller G4, Toumi M5
1Creativ Ceutical, Paris, Ile de France, France, 2CREATIV-CEUTICAL, Paris, France, 3Pierre &
Marie Curie University, Paris, France, 4Creativ-Ceutical, Luxembourg, Luxembourg, 5University
Claude Bernard Lyon1, Lyon, France
OBJECTIVES: Clinical studies generally include several endpoints to compare the
effects of alternative interventions. Meta-analyses are usually performed on dif-
ferent endpoints separately. We investigated advantages of bivariate meta-analy-
sis models, accounting for the correlation between endpoints, compared to univar-
iate meta-analyses. METHODS: Alternative meta-analysis approaches were
applied and compared using simulated datasets of logarithms of odds ratios (OR)
for two endpoints. Several datasets of 20 studies were simulated, with different
correlations between endpoints, and with or without missing values. Simulations
were based on a bivariate normal distribution with mean log ORs of -0.5, corre-
sponding to ORs of 0.61, and variances of 0.25 for both endpoints. The models used
were: 1) random-effects univariate models for each endpoint separately; 2) two-
stage approach using univariate model for studies with one endpoint and bivariate
model for studies with two endpoints; and 3) bivariate model with prior imputation
of the variance of second endpoint for studies with one endpoint only, based on the
correlation between variances for the two endpoints. All the models were esti-
mated in a Bayesian framework, using WinBugs. RESULTS: Results of different
models were fairly similar in absence of missing data. In a situation with one
endpoint missing at random for 10 studies, and a correlation of 0.8, the bias around
estimated OR for that endpoint was 0.12, 0.03, and 0.04 with models 1, 2 and 3
respectively, when an informative prior was used for the correlation. The bias was
not reduced with uninformative prior. Variance estimates also differed between
models, and were very large with model 2 for some simulations. CONCLUSIONS:
Bivariate meta-analysis can improve treatment effect estimates when information
is collected for two correlated endpoints, especially for an endpoint which is not
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